Propofol - NanoMedex Pharmaceuticals

Drug Profile

Propofol - NanoMedex Pharmaceuticals

Alternative Names: Macrofol

Latest Information Update: 14 Jul 2016

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator NanoMedex Pharmaceuticals
  • Developer NanoMedex
  • Class General anaesthetics; Phenols; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Anaesthesia; Sedation

Most Recent Events

  • 14 Jul 2016 Chemical structure information added
  • 08 Jul 2016 Preclinical trials in Anaesthesia in USA (IV)
  • 08 Jul 2016 Preclinical trials in Sedation in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top